WALTHAM, Mass., May 23, 2008 (BUSINESS WIRE) -- Phase Forward (NASDAQ: PFWD), a leading provider of data
management solutions for clinical trials and drug safety, has been
named by the Software & Information Industry Association (SIIA) as the
winner of the 2008 CODiE Award for Best Medical and Health Information
Product for its InForm(TM) Integrated Trial Management (ITM) 4.6
product.
Successfully used in more than 2,300 trials, the InForm electronic
data capture (EDC) solution delivers end-to-end electronic clinical
data management (eCDM) capabilities to sponsors and sites that rely on
the capture, management and evaluation of collected clinical trial
data.
The CODiE Awards, now in their 23rd year, use both journalist and
peer-company reviews to identify the leaders and innovators in
categories across the software, digital content and education
technology industries. This year's winners were chosen from more than
1,100 nominations submitted by more than 600 companies for the
excellence of their products, services, corporate leadership and
philanthropy.
"The 2008 CODiE Awards recognize those companies providing the
best new technology products and services across a broad array of
industries," noted SIIA President Ken Wasch. "The awards and their
winners are a testament to the power of technology to deliver
innovative solutions to American businesses and consumers. SIIA
congratulates all of the CODiE Award winners and nominees, whose
innovation is essential for continuing America's leadership in the
global knowledge economy."
"We are gratified by the recognition offered by SIIA," said Bob
Weiler, CEO and president, Phase Forward. "We are pleased to accept
this award on behalf of our customers, whose use of InForm reflects
their commitment to leveraging technological innovation to bring drugs
to market more safely and efficiently, and also our employees, whose
dedication and commitment are clearly reflected in the product."
Winners were announced on May 20 at the CODiE Awards Gala at the
Palace Hotel in San Francisco, CA. For a complete listing of all the
award winners, visit: http://www.siia.net/codies/2008/finalists.asp.
About SIIA
The Software & Information Industry Association (SIIA) is the
principal trade association for the software and digital content
industry. SIIA provides global services in government relations,
business development, corporate education and intellectual property
protection to more than 800 leading software and information
companies. For further information, visit www.siia.net.
About Phase Forward
Phase Forward is a leading provider of integrated data management
solutions for clinical trials and drug safety. The company offers
proven solutions for electronic data capture (InForm(TM)), phase I
clinic automation (LabPas(TM)), clinical data management
(Clintrial(TM)), clinical trials signal detection (CTSD(TM)),
strategic pharmacovigilance (WebVDME(TM) and Signal Management),
adverse event reporting (Empirica(TM) Trace) and applied data
standards (WebSDM(TM)). In addition, the company provides services in
the areas of application implementation, hosting and validation, data
integration, business process optimization, safety data management and
industry standards. Phase Forward's products and services have been
utilized in over 10,000 clinical trials involving more than 1,000,000
clinical trial study participants at over 280 organizations and
regulatory agencies worldwide including: AstraZeneca, Boston
Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and
Drug Administration, GlaxoSmithKline, Harvard Clinical Research
Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL
International, Procter & Gamble, Quintiles, sanofi-aventis,
Schering-Plough Research Institute, Servier, Tibotec and the U.K.
Medicines and Healthcare Products Regulatory Agency. Additional
information about Phase Forward is available at www.phaseforward.com.
Cautionary Statement
Certain statements made in this press release that are not based
on historical information are forward-looking statements which are
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. This press release contains express or
implied forward-looking statements relating to, among other things,
the performance of Phase Forward's products and services, continued
market acceptance of Phase Forward's products and services, and the
ability of Phase Forward's customers to realize benefits from the use
of Phase Forward's products and services. These statements are neither
promises nor guarantees, but are subject to a variety of risks and
uncertainties, many of which are beyond Phase Forward's control, which
could cause actual results to differ materially from those
contemplated in these forward-looking statements. In particular, the
risks and uncertainties include, among other things, the ability of
Phase Forward's customers to realize benefits from the use of its
products and services, the possibility that customers' needs or plans
may change over time, and the introduction or improvement of products
and services competitive with those of Phase Forward. Existing and
prospective investors are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date
hereof. Phase Forward undertakes no obligation to update or revise the
information contained in this press release, whether as a result of
new information, future events or circumstances or otherwise. For
additional disclosure regarding these and other risks faced by Phase
Forward, see the disclosure contained in Phase Forward's public
filings with the Securities and Exchange Commission including, without
limitation, its most recent Annual Report on Form 10-K.
SOURCE: Phase Forward
Phase Forward
Elaine Maynard, 781-902-4371
elaine.maynard@phaseforward.com
or
CHEN PR, Inc.
Meghan Locke, 781-672-3147
mlocke@chenpr.com
